News

Follow:
14053 Articles

FDA Has Approved The Anti-Alzheimer’s Drug Leqembi. What You Need To Know

The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers

By News

David Einhorn Builds Up Green Brick Partners Stake

Summary The position was increased by 4.98%. The company recently reported a record quarter. After reducing his stake in Green

By News

Mortgage rates inch to the highest level so far this year: Freddie Mac

Rising mortgage rates and low housing supply continued to make homebuying a challenging prospect for would-be buyers, according to Freddie

By News

How Aristotle’s Four Levels Work In Business

Jordan Peace is Co-Founder & CEO of Fringe, the first lifestyle benefits marketplace, and Greenhouse Money, financial services. It’s no

By News

PHD: A Laggard In The Leveraged Loan CEF World

Thesis Pioneer Floating Rate Fund (NYSE:PHD) is a leveraged loan CEF. The fund has a classic structure, with its composition

By News

How To Retire At 60 With A 9.5% Dividend Stream

TV personality Suze Orman has bad news for anyone hoping to escape the rat race: they’ll probably have to wait

By News

As Women, We Need To Speak Up And Stand Together

Maria Tedesco, President and Chief Operating Officer at Atlantic Union Bank. Earlier this year, I was involved in a casual

By News

Palo Alto: AI And XSIAM Drive Investor Excitement (NASDAQ:PANW)

Back in April, I wrote that while Palo Alto (NASDAQ:PANW) has a big opportunity to grow its SASE business and

By News